John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$297M |
| 2 |
Bank of America
BAC
|
+$249M |
| 3 |
Oracle
ORCL
|
+$247M |
| 4 |
Microsoft
MSFT
|
+$246M |
| 5 |
Snap
SNAP
|
+$243M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$260M |
| 2 |
Merck
MRK
|
+$260M |
| 3 |
S&P Global
SPGI
|
+$233M |
| 4 |
Occidental Petroleum
OXY
|
+$221M |
| 5 |
Walmart Inc
WMT
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.21% |
| 2 | Healthcare | 13.54% |
| 3 | Financials | 11.06% |
| 4 | Industrials | 10.41% |
| 5 | Consumer Discretionary | 7.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AHG
2226
Akso Health Group
AHG
$808M
| $122K | ﹤0.01% |
119,721
-14,131
| -11% | -$16K |
|
2227
Village Farms International
VFF
$331M
| $122K | ﹤0.01% |
+46,792
| New | +$170K |
|
2228
Smith Micro Software
SMSI
$16.7M
| $121K | ﹤0.01% |
+1,220
| New | +$142K |
|
|
LUXA
2229
DELISTED
Lux Health Tech Acquisition Corp. Class A Common Stock
LUXA
| $119K | ﹤0.01% |
+12,000
| New | +$118K |
|
|
YSG
2230
Yatsen Holding
YSG
$281M
| $115K | ﹤0.01% |
14,859
-507,906
| -97% | -$1.73M |
|
|
BTTX
2231
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
| $115K | ﹤0.01% |
73,800
+8,008
| +12% | +$13.4K |
|
|
AATC
2232
DELISTED
Autoscope Technologies Corporation Common Stock
AATC
| $115K | ﹤0.01% |
20,983
-9,888
| -32% | -$59.5K |
|
2233
Rimini Street
RMNI
$486M
| $113K | ﹤0.01% |
18,800
-119,800
| -86% | -$713K |
|
2234
Pliant Therapeutics
PLRX
$70.6M
| $112K | ﹤0.01% |
14,000
-111,278
| -89% | -$712K |
|
|
SYBX
2235
DELISTED
Synlogic
SYBX
| $112K | ﹤0.01% |
6,487
-2,184
| -25% | -$47.2K |
|
2236
Amtech Systems
ASYS
$245M
| $111K | ﹤0.01% |
15,200
-14,040
| -48% | -$121K |
|
|
DMRA
2237
Damora Therapeutics
DMRA
$1.87B
| $110K | ﹤0.01% |
2,532
-3,215
| -56% | -$147K |
|
|
WHLM
2238
DELISTED
Wilhelmina International, Inc
WHLM
| $109K | ﹤0.01% |
24,727
-1,005
| -4% | -$4.62K |
|
2239
Cumberland Pharmaceuticals
CPIX
$117M
| $107K | ﹤0.01% |
51,502
-37,581
| -42% | -$86.9K |
|
2240
EyePoint Inc
EYPT
$420M
| $107K | ﹤0.01% |
13,562
-5,894
| -30% | -$59.3K |
|
2241
Orion Group Holdings
ORN
$369M
| $106K | ﹤0.01% |
46,305
+10,879
| +31% | +$28K |
|
|
IDEX
2242
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $106K | ﹤0.01% |
1,282
-5,338
| -81% | -$481K |
|
2243
GeoVax Labs
GOVX
$3.58M
| $104K | ﹤0.01% |
335
+262
| +359% | +$115K |
|
2244
Verrica Pharmaceuticals
VRCA
$83.7M
| $104K | ﹤0.01% |
+5,427
| New | +$273K |
|
2245
Cabaletta Bio
CABA
$526M
| $102K | ﹤0.01% |
96,210
-53,719
| -36% | -$76K |
|
2246
Pyxis Oncology
PYXS
$247M
| $101K | ﹤0.01% |
+42,296
| New | +$113K |
|
2247
Sphere 3D
ANY
$21.2M
| $100K | ﹤0.01% |
2,666
+2,097
| +369% | +$181K |
|
2248
Rigetti Computing
RGTI
$5.46B
| $99K | ﹤0.01% |
+26,997
| New | +$172K |
|
2249
Extreme Networks
EXTR
$2.92B
| $98K | ﹤0.01% |
10,937
-59,100
| -84% | -$601K |
|
|
SCOB
2250
DELISTED
ScION Tech Growth II Class A Ordinary Shares
SCOB
| $98K | ﹤0.01% |
+10,000
| New | +$98.1K |
|
Similar funds
John Overdeck's Q2 2022 Portfolio in Review
As of Q2 2022, John Overdeck held 3,177 positions worth $30.3B, down 11% from $33.9B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.
John Overdeck deployed $2.33B of net new capital in Q2 2022, opening 628 new positions and adding to 764 existing holdings. Its largest new stake was Meta Platforms (Facebook): 1,541,482 shares worth $249M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Merck, an estimated $260M trimmed.
- John Overdeck's largest Q2 2022 buy was Meta Platforms (Facebook): 1,541,482 shares worth $249M.
- John Overdeck added most to Bank of America in Q2 2022, an estimated $249M increase.
- John Overdeck's biggest Q2 2022 reduction was Merck, cutting an estimated $260M.
- John Overdeck fully exited Tesla in Q2 2022, selling an estimated $260M.
- John Overdeck's ten largest holdings make up 8.2% of its $30.3B portfolio in Q2 2022.
- John Overdeck opened 628 new positions and closed 730 in Q2 2022.
- John Overdeck's portfolio value fell 11% quarter-over-quarter to $30.3B.
Based on Two Sigma Investments's 13F filing for Q2 2022, filed 15 Aug 2022.